HUP0500100A2 - 1,3-Diarilprop-2-én-1-on-származékok, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk - Google Patents
1,3-Diarilprop-2-én-1-on-származékok, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásukInfo
- Publication number
- HUP0500100A2 HUP0500100A2 HU0500100A HUP0500100A HUP0500100A2 HU P0500100 A2 HUP0500100 A2 HU P0500100A2 HU 0500100 A HU0500100 A HU 0500100A HU P0500100 A HUP0500100 A HU P0500100A HU P0500100 A2 HUP0500100 A2 HU P0500100A2
- Authority
- HU
- Hungary
- Prior art keywords
- carbon atom
- group
- alkyl
- trimethoxyphenyl
- atom alkyl
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 COO(R4) Chemical group 0.000 abstract 7
- 229910052799 carbon Inorganic materials 0.000 abstract 6
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- 101100054666 Streptomyces halstedii sch3 gene Proteins 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
- C07C279/32—N-nitroguanidines
- C07C279/36—Substituted N-nitroguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Bending Of Plates, Rods, And Pipes (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0115739A FR2833008B1 (fr) | 2001-12-05 | 2001-12-05 | 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation |
FR0214217 | 2002-11-14 | ||
PCT/FR2002/004143 WO2003048106A2 (fr) | 2001-12-05 | 2002-12-03 | 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0500100A2 true HUP0500100A2 (hu) | 2005-05-30 |
Family
ID=26213287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0500100A HUP0500100A2 (hu) | 2001-12-05 | 2002-12-03 | 1,3-Diarilprop-2-én-1-on-származékok, az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1453790A2 (fr) |
JP (1) | JP2005531494A (fr) |
KR (1) | KR20050044712A (fr) |
CN (1) | CN1612856A (fr) |
AR (1) | AR037479A1 (fr) |
AU (1) | AU2002365644A1 (fr) |
BR (1) | BR0214694A (fr) |
CA (1) | CA2469193A1 (fr) |
CO (1) | CO5580759A2 (fr) |
EA (1) | EA006803B1 (fr) |
HR (1) | HRP20040508A2 (fr) |
HU (1) | HUP0500100A2 (fr) |
IL (1) | IL162223A0 (fr) |
MA (1) | MA27351A1 (fr) |
MX (1) | MXPA04005226A (fr) |
NZ (1) | NZ533224A (fr) |
PA (1) | PA8558501A1 (fr) |
PE (1) | PE20030758A1 (fr) |
PL (1) | PL370676A1 (fr) |
RS (1) | RS47804A (fr) |
SV (1) | SV2003001422A (fr) |
TW (1) | TW200300685A (fr) |
WO (1) | WO2003048106A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2854399B1 (fr) * | 2003-04-30 | 2006-11-17 | Aventis Pharma Sa | 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation |
EP1598353A1 (fr) * | 2004-05-17 | 2005-11-23 | Boehringer Ingelheim International GmbH | Pyrrolobenzimidazolones et leur utilisation en tant qu'agents antiproliferatifs |
WO2017103637A1 (fr) | 2015-12-18 | 2017-06-22 | Blirt S.A. | Composés de diphénylpropane et leur activité cytotoxique |
CN109467549B (zh) * | 2018-12-07 | 2021-02-09 | 中国药科大学 | 喹啉取代查尔酮类化合物、其制备方法及用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4904697A (en) * | 1987-04-09 | 1990-02-27 | Merrell Dow Pharmaceuticals Inc. | Controlling the growth of certain tumor tissue with chalcone derivatives |
JPH08277242A (ja) * | 1995-02-08 | 1996-10-22 | Kyowa Hakko Kogyo Co Ltd | プロペノン誘導体 |
BR9607708A (pt) * | 1995-12-01 | 1998-01-13 | Kyowa Hakko Kogyo Kk | Derivado de propenona |
WO1999000114A2 (fr) * | 1997-06-26 | 1999-01-07 | Statens Serum Institut | 1,3-bis-aromatique-prop-2-en-1-ones, 1,3-bis-aromatique-propane-1-ones et 1,3-bis-aromatique-prop-2-yn-1-ones a action biologique |
-
2002
- 2002-11-21 PE PE2002001118A patent/PE20030758A1/es not_active Application Discontinuation
- 2002-11-22 PA PA20028558501A patent/PA8558501A1/es unknown
- 2002-11-26 TW TW091134346A patent/TW200300685A/zh unknown
- 2002-11-29 AR ARP020104618A patent/AR037479A1/es unknown
- 2002-12-02 SV SV2002001422A patent/SV2003001422A/es not_active Application Discontinuation
- 2002-12-03 JP JP2003549299A patent/JP2005531494A/ja not_active Abandoned
- 2002-12-03 EP EP02804242A patent/EP1453790A2/fr not_active Withdrawn
- 2002-12-03 CA CA002469193A patent/CA2469193A1/fr not_active Abandoned
- 2002-12-03 KR KR1020047008656A patent/KR20050044712A/ko not_active Application Discontinuation
- 2002-12-03 PL PL02370676A patent/PL370676A1/xx unknown
- 2002-12-03 WO PCT/FR2002/004143 patent/WO2003048106A2/fr not_active Application Discontinuation
- 2002-12-03 BR BR0214694-0A patent/BR0214694A/pt not_active IP Right Cessation
- 2002-12-03 CN CNA028268601A patent/CN1612856A/zh active Pending
- 2002-12-03 RS YU47804A patent/RS47804A/sr unknown
- 2002-12-03 EA EA200400764A patent/EA006803B1/ru not_active IP Right Cessation
- 2002-12-03 HU HU0500100A patent/HUP0500100A2/hu unknown
- 2002-12-03 MX MXPA04005226A patent/MXPA04005226A/es unknown
- 2002-12-03 NZ NZ533224A patent/NZ533224A/xx unknown
- 2002-12-03 AU AU2002365644A patent/AU2002365644A1/en not_active Abandoned
- 2002-12-03 IL IL16222302A patent/IL162223A0/xx unknown
-
2004
- 2004-06-01 MA MA27708A patent/MA27351A1/fr unknown
- 2004-06-03 CO CO04052091A patent/CO5580759A2/es not_active Application Discontinuation
- 2004-06-04 HR HR20040508A patent/HRP20040508A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2005531494A (ja) | 2005-10-20 |
RS47804A (en) | 2006-12-15 |
MXPA04005226A (es) | 2004-10-11 |
EP1453790A2 (fr) | 2004-09-08 |
CA2469193A1 (fr) | 2003-06-12 |
HRP20040508A2 (en) | 2005-08-31 |
IL162223A0 (en) | 2005-11-20 |
SV2003001422A (es) | 2003-07-10 |
MA27351A1 (fr) | 2005-06-01 |
EA006803B1 (ru) | 2006-04-28 |
KR20050044712A (ko) | 2005-05-12 |
AR037479A1 (es) | 2004-11-10 |
BR0214694A (pt) | 2004-12-14 |
WO2003048106A2 (fr) | 2003-06-12 |
CO5580759A2 (es) | 2005-11-30 |
WO2003048106A3 (fr) | 2004-03-25 |
EA200400764A1 (ru) | 2004-12-30 |
AU2002365644A1 (en) | 2003-06-17 |
PA8558501A1 (es) | 2003-09-05 |
NZ533224A (en) | 2006-03-31 |
PL370676A1 (en) | 2005-05-30 |
CN1612856A (zh) | 2005-05-04 |
PE20030758A1 (es) | 2003-10-07 |
TW200300685A (en) | 2003-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402311A2 (hu) | Naftiridinszármazékok, eljárás előállításukra, és alkalmazásuk foszfodiészteráz izoenzim 4 (PDE4) gátló hatóanyagként és ezeket tartalmazó gyógyszerkészítmények | |
HUP0103460A2 (hu) | Vírusellenes hatású indolszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP0004400A2 (hu) | Dipeptid-nitrilek, eljárás előállításukra, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0400888A2 (hu) | Helyettesített ciklohexán-1,4-diamin-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0401783A2 (hu) | 3,4-Diszubsztituált ciklobutén-1,2-dionok mint CXC-kemokin receptor ligandumok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
HUP0302167A2 (hu) | Metabotropikus glutamát receptor antagonista hatású kinolinszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
HUP0400704A2 (hu) | Heterociklusos éterrel szubsztituált imidazokinolinok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
HUP0004082A2 (hu) | Adenozinszármazékok, eljárás előállításukra azokat hatóanyagként tartalmazó gyógyszerkészítmények, valamint ilyen hatóanyagok alkalmazása gyógyszerkészítmények előállítására | |
FI921030A (fi) | Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning | |
MXPA04001240A (es) | Analogos antitumorales. | |
SE0202133D0 (sv) | Novel compounds | |
HUP0400323A2 (hu) | Tirozin-kináz inhibitorok és a vegyületeket tartalmazó gyógyszerkészítmények | |
ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
CY1111543T1 (el) | Νεες ενωσεις | |
HUP0401643A2 (hu) | Szubsztituált karbamid neuropeptid Y Y5 receptor antagonisták, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
HUP0401293A2 (hu) | Új dihidropteridinonok, eljárás előállításukra és alkalmazásuk gyógyszerként | |
HUP0301508A2 (hu) | Antivirális hatású aza-indol-származékok és ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek | |
HUP0303729A2 (hu) | Akridinszármazékok és azok gyógyszerként történő alkalmazása és eljárás az előállításukra | |
DE60212949D1 (de) | Antivirale pyrazolopyridin verbindungen | |
HUP0002843A2 (hu) | Új béta-karbolin-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
HUP0203288A2 (hu) | Foszfodiészteráz VII inhibitor hatású pirrolszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0201356A2 (hu) | Ösztrogén agonisták/antagonisták alkalmazása depresszió kezelésére vagy a kognitív funkció romlásának megelőzésére alkalmas gyógyászati készítmény előállítására | |
HUP0104033A2 (hu) | Benzoilpiridazin-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás az előállításukra és alkalmazásuk | |
GEP20084306B (en) | Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them | |
HUP0301567A2 (hu) | Új szubsztituált ftalidok, eljárás elżállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |